If you or a loved one has suffered any type of injury or a loved one has died due to taking the prescription drug, Multaq, any injured or grieving person must act quickly to protect their legal right to a potentially substantial cash award settlement. The legal clock is ticking, which is why you need to speak with our expert and board certified, Multaq side effects lawyer at Roberts & Roberts. Contact us to learn if you qualify for compensation related to pain and suffering, medical expenses, loss of employment income and more. Our nationwide leading law firm offers a free consultation that could lead to a far better financial life simply by calling us at (903) 597-6000.
Multaq (dronedarone) is marketed by its manufacturer, Sanofi-Aventis, and the drug had won FDA approval in July, 2009 as a, supposedly, stringently controlled treatment for atrial fibrillation (irregular heartbeat), a potentially life-threatening cardiac disorder. Upon its release, the FDA had ordered that the drug only be prescribed in association with comprehensive Risk Evaluation and Mitigation study and prescribing practices. The federal agency’s strict requirement for patient monitoring was a result of Multaq’s potential for an increased risk of death for individuals who had already experienced some form of heart failure, as well as patients who had been recently hospitalized for cardiac failure.
Approximately a half million patients in the U.S. had been prescribed Multaq within the first two years following its release. Numerous lawsuits allege that many of these patients were either exposed to or suffered serious side effects, including death from a drug that carried no warning label of its significant dangers. In addition to Multaq’s very real cardiac risks, Multaq use has also been associated with strokes, as well as serious liver damage or total organ failure resulting in the need for a liver transplant.
The FDA had warned Sanofi about its failure to inform them, in a required timely manner, about reported injuries or deaths related to Multaq use, and numerous lawsuits charge that Sanofi knew well the potentially lethal side effects of its cardiac drug. In July, 2011, the company cancelled a study of Multaq because the drug had been deemed to be too dangerous to administer to control group patients. In light of all this, the pharmaceutical company refuses to pull the drug from American pharmacy shelves, thus exposing countless more patients to it dangers. Such willfully negligent actions also expose the drug company to the many lawsuits now pending against it.
If you or a loved one has suffered an injury or the tragic death of a loved one due to Multaq use, be certain to make today the day you speak to a professionally leading and highly experienced, Texas personal injury lawyer at Roberts & Roberts. Our eligibility for compensation consultation will cost you nothing, but it could mean a far brighter financial future simply by calling us at (903) 597-6000. With our dedicated, Multaq side effects lawyer fighting hard at your side, you’ll get the optimal results you deserve!